pING-hHER3FL
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for pING-hHER3FL, covering 2025-07-03 to 2025-07-03. Get the full timeline:
Most recent: Clinical Trial Update: Assessing the Immunogenicity of pING-hHER3FL [Phase 1]